PedAM
Pediatric Disease Annotations & Medicines
| Disease | lymphoma |
| Phenotype | C0003873|rheumatoid arthritis |
| Sentences | 20 |
| PubMedID- 26271620 | 5relative risk of non-hodgkin lymphoma in patients with rheumatoid arthritis (ra) compared with the general population. |
| PubMedID- 19674036 | Symmetrical primary cutaneous marginal zone lymphoma associated with rheumatoid arthritis. |
| PubMedID- 25810835 | Oral non-hodgkin's lymphoma in a patient with rheumatoid arthritis treated with etanercept and methotrexate. |
| PubMedID- 25452189 | Prolonged remission of marginal zone lymphoma in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor agents. |
| PubMedID- 24811465 | Nasal type extranodal nk/t cell lymphoma diagnosed in a patient with rheumatoid arthritis under methotrexate. |
| PubMedID- 22825547 | Epstein-barr virus and methotrexate-related cns lymphoma in a patient with rheumatoid arthritis. |
| PubMedID- 23793110 | Significant igg4+ plasma cell infiltrates were observed in rheumatoid arthritis, granulomatosis with polyangiitis, and lymphoma, underscoring the importance of histopathology in making the diagnosis of igg4-rd. |
| PubMedID- 26248810 | An unusual presentation of lymphoma in a patient with rheumatoid arthritis in remission. |
| PubMedID- 26236588 | Several studies have suggested an increased risk of lymphoma in patients with rheumatoid arthritis (ra). |
| PubMedID- 21729669 | The relationship between anti-tnf therapy and development of lymphoma in rheumatoid arthritis (ra) patients is controversial. |
| PubMedID- 20098085 | Composite cutaneous lymphoma in a patient with rheumatoid arthritis treated with methotrexate. |
| PubMedID- 19851770 | Anaplastic large cell lymphoma in a patient with rheumatoid arthritis. |
| PubMedID- 25748956 | Methotrexate-related primary hepatic lymphoma in a patient with rheumatoid arthritis. |
| PubMedID- 21369647 | The sir for lymphoma for patients with rheumatoid arthritis was 3.45 (1.83-5.89); all other indications reported sirs similar to those observed in the general population. |
| PubMedID- 23705580 | We report the first case of primary central nervous system lymphoma (pcnsl) developing in a patient with rheumatoid arthritis (ra) undergoing low-dose methotrexate therapy (ld-mtx). |
| PubMedID- 23709423 | Use of immunosuppressive agents is also associated with lymphoproliferative disorders, as shown in methotrexate-related lymphoma in patients with rheumatoid arthritis.38 furthermore, reactivation or de novo infection of various pathogens, such as epstein-barr virus and human t-lymphotropic virus-1, are involved in not only hematological malignancies but also in several autoimmune and rheumatic diseases,39,40 which may be a consequence of therapeutic immunosuppression.41 the relationships between solid cancers, excluding the aforementioned cancers, and bd seem to be incidental. |
| PubMedID- 21829083 | [b-cell lymphoma possessing t(14;18)(q32;q21)in a patient with rheumatoid arthritis receiving methotrexate treatment]. |
| PubMedID- 19705304 | Primary thyroid marginal zone b-cell lymphoma malt-type in a patient with rheumatoid arthritis. |
| PubMedID- 25610674 | Primary hepatic lymphoma in a patient with rheumatoid arthritis treated with methotrexate. |
| PubMedID- 26509060 | Late-onset neutropenia rituximab was mainly reported in patients treated for lymphoma but data in patients with rheumatoid arthritis and other aids are very limited. |
Page: 1